List of insiders holdings for Passage BIO Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Lynx1 Capital Management LP Nichols Weston 10% Owner |
2025-02-14 09:01:32 | 9,256,953 0 |
9,256,953 | Form 13G |
2 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC 10% Owner |
2025-04-17 18:10:47 | 0 6,885,572 |
6,885,572 | Form 4 |
3 | Heron Patrick J Director 10% Owner |
2020-03-03 18:54:26 | 0 5,009,219 |
5,009,219 | Form 4 |
4 | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N 10% Owner |
2023-06-15 10:25:28 | 2,543,698 0 |
2,543,698 | Form 13D |
5 | Chou William PRESIDENT AND CEO |
2025-03-18 17:11:39 | 779,533 0 |
779,533 | Form 4 |
6 | Quigley Jill M. Chief Operating Officer |
2021-12-10 17:30:22 | 400,109 3,608 |
403,717 | Form 4 |
7 | Romano Gary Chief Medical Officer |
2021-03-17 21:12:42 | 300,821 0 |
300,821 | Form 4 |
8 | Borthwick Kathleen CFO |
2025-03-18 17:12:20 | 278,386 0 |
278,386 | Form 4 |
9 | Cale Edgar B. GC & CORPORATE SECRETARY |
2025-03-18 17:11:05 | 278,386 0 |
278,386 | Form 4 |
10 | SQUINTO STEPHEN P Head of Research and Dev |
2020-03-02 17:42:09 | 219,612 0 |
219,612 | Form 4 |
11 | Forman Mark S CHIEF MEDICAL OFFICER |
2024-03-19 16:09:54 | 203,000 0 |
203,000 | Form 4 |
12 | Kassberg Thomas Richard Director |
2024-10-02 16:35:20 | 174,139 0 |
174,139 | Form 4 |
13 | Salinas Eliseo Oreste Chief Res. & Develop Officer |
2022-02-14 17:21:20 | 157,500 0 |
157,500 | Form 4 |
14 | Goldsmith Bruce A CEO and President |
2022-06-01 16:25:24 | 100,000 0 |
100,000 | Form 4 |
15 | Fotopoulos Alexandros Chief Technical Officer |
2023-06-20 16:10:44 | 53,693 0 |
53,693 | Form 4 |
16 | Islam Saqib Director |
2024-05-23 16:53:37 | 47,693 0 |
47,693 | Form 4 |
17 | Countouriotis Athena Director |
2024-05-23 17:43:57 | 47,693 0 |
47,693 | Form 4 |
18 | GOWEN MAXINE Director |
2024-05-23 16:56:03 | 47,693 0 |
47,693 | Form 4 |
19 | Kapadia Sandip Director |
2024-05-23 16:55:06 | 47,693 0 |
47,693 | Form 4 |
20 | Porter Derrell Director |
2024-05-23 16:51:39 | 47,693 0 |
47,693 | Form 4 |
21 | Sondhi Dolan Director |
2024-05-23 16:52:31 | 39,092 0 |
39,092 | Form 4 |
22 | Burkavage Brian Controller |
2021-06-09 18:30:13 | 30,829 0 |
30,829 | Form 3 |
23 | Woiwode Thomas Director 10% Owner |
2023-05-26 16:38:02 | 24,000 0 |
24,000 | Form 4 |
24 | King Simona Chief Financial Officer |
2023-08-01 16:36:49 | 23,994 0 |
23,994 | Form 4 |
25 | Kamarck Michael E. Director |
2023-05-26 16:31:58 | 21,567 0 |
21,567 | Form 4 |
26 | Toernsen Monika Maria Chief Commercial Officer |
2022-11-18 17:01:06 | 18,319 0 |
18,319 | Form 4 |
27 | Yamada Tadataka Director |
2021-05-28 18:04:38 | 16,918 0 |
16,918 | Form 4 |
28 | Ratcliffe Liam Director |
2021-05-28 17:58:14 | 16,918 0 |
16,918 | Form 4 |
29 | Morris Richard Steven Chief Financial Officer |
2021-05-21 18:09:24 | 5,454 0 |
5,454 | Form 4 |
30 | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Woiwode Thomas 10% Owner |
2024-08-09 19:06:55 | 0 0 |
0 | Form 13D |